Blood Biomarkers for Neurodegeneration

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

93 papers

Active filtersClassification:Supporting

Showing 1-12 of total 93 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026CrossrefSupporting evidence0 citations

Inflammasomes: central mediators of neuroinflammatory neurodegeneration in Alzheimer’s and Parkinson’s disease

Clémence Tropis; Janna Jernigan Posey; Malú Gámez Tansey; Michael T. Heneka

Sep 5, 2026Molecular Neurodegeneration

2026CrossrefSupporting evidence0 citations

Investigation of Serum Neurofilament Light Chain as a Surrogate for Cerebrospinal Fluid Neurofilament Light Chain in Canine Cognitive Dysfunction Syndrome

Chih-Ching Wu; Wei-Hsiang Huang; Ya-Pei Chang

Aug 25, 2026Animals

2026CrossrefSupporting evidence0 citations

Advancing a systems-level understanding of neurodegeneration: the BrightFocus Alzheimer’s disease research portfolio

Sharyn L. Rossi; Diane E. Bovenkamp

Aug 21, 2026Molecular Neurodegeneration

2026PubMedSupporting evidence

Excitation-inhibition imbalance links amyloid pathophysiology to cognition in non-demented individuals.

Zhang S; Roemer-Cassiano SN; Chong JR; Fang T; Li Y; Wang Z; Zeng T; Li X; Deco G; Venketasubramanian N; Zhou JH; Chen CL; Alzheimer's Disease Neuroimaging Initiative; Lai MKP; Franzmeier N; Yeo BTT

Jan 1, 2026Alzheimer's & dementia : the journal of the Alzheimer's Association

2026PubMedSupporting evidence

Highly sensitive and specific high-throughput detection of Aβ42 in clinical specimens using a G-quadruplex-structured fluorescent aptamer analysis platform.

Cui M; Yang J; Zhao LS; Hu X; Cong W; Hu H; Xu F; Liu S

Jan 1, 2026Talanta

2026PubMedSupporting evidence

The Impact of Age, Comorbidity, and Current Medication Use on Plasma p-tau217 in Adolescents: A Pilot Study.

Stancil SL; Brewe ME; Mayfield H; Morris J

Jan 1, 2026The journal of applied laboratory medicine

2026PubMedSupporting evidence

Erinacine C Attenuates Alzheimer's-like Pathology: A Study in APP/PS1 Mice and PC12 Cells.

Wang LY; Yeh SL; Hsu ST; Huang SM; Chau CF; Chuang CH

Jan 1, 2026Molecules (Basel, Switzerland)

2026PubMedSupporting evidence

Bioengineered microbiotic levodopa therapy improves cognition and reduces pathology in a rat model of Alzheimer's disease.

Abdelhamid M; Padhi P; Gifani M; Beck JS; Thomas JP; Khadse G; Kudela C; Phillips GJ; Kanthasamy AG; Counts SE

Jan 1, 2026British journal of pharmacology

2026PubMedSupporting evidence

Trans-Vitisin B Targets Neuroinflammation, Oxidative Stress, and Tau Pathology to Improve Behavioral Outcomes in a Mouse Model of Parkinson's Disease.

Pislyagin E; Manzhulo I; Agafonova I; Starinets A; Menchinskaya E; Chingizova E; Tarbeeva D; Fedoreyev S; Aminin D

Jan 1, 2026Antioxidants (Basel, Switzerland)

2026PubMedSupporting evidence

Association of plasma biomarkers with longitudinal change in age- and Alzheimer's disease-related brain atrophy patterns.

Bilgel M; Shah I; Cooper J; An Y; Walker KA; Ho SG; Moghekar AR; Yang Z; Erus G; Davatzikos C; Ferrucci L; Resnick SM

Jan 1, 2026medRxiv : the preprint server for health sciences

2026PubMedSupporting evidence

Screening GGC repeat expansion in the NOTCH2NLC in early-onset dementia: The Longitudinal Study of Early Onset Dementia and Family Members (LEAF) Study.

Lee SY; Mizuguchi T; Kim HJ; Kim YE; Hanna C; Kim WJ; Lee GH; Kim A; Park JY; Chung EJ; Jang H; Jung NY; Lee SM; Seo SW; Koh SH; Zetterberg H; G Apostolova L; Matsumoto N; Moon SY; Kim EJ; LEAF investigators

Jan 1, 2026Alzheimer's & dementia (Amsterdam, Netherlands)

2026PubMedSupporting evidence

Reframing Alzheimer's Disease Through a Redox-Metabolic Framework.

Velázquez De Castro-Bono A; Castro-Luna G; Guil-Guerrero JL

Jan 1, 2026International journal of molecular sciences